Company Filing History:
Years Active: 2001-2005
Title: The Innovative Contributions of Scott S. Ceglia
Introduction
Scott S. Ceglia is a notable inventor based in Woodbridge, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for phosphodiesterase-4. With a total of 2 patents to his name, Ceglia's work has the potential to impact various therapeutic areas.
Latest Patents
Ceglia's latest patents include a method of preparing inhibitors of phosphodiesterase-4. This invention focuses on a one-pot method of preparing intermediates that are useful in creating these inhibitors. Additionally, he has developed a method for preparing crystalline salts of a carbapenem antibiotic, which addresses the stability issues associated with an amorphous, unstable carbapenem antibiotic.
Career Highlights
Scott S. Ceglia is currently employed at Merck & Co., Inc., a leading global healthcare company. His role at Merck allows him to work on cutting-edge pharmaceutical innovations that aim to improve patient outcomes. Ceglia's expertise in the field has positioned him as a valuable asset to his team and the company.
Collaborations
Ceglia has collaborated with several talented individuals in his field, including Jennifer Albaneze-Walker and Jerry Anthony Murry. These collaborations have likely contributed to the success of his innovative projects and patents.
Conclusion
Scott S. Ceglia's contributions to the pharmaceutical industry through his patents and work at Merck & Co., Inc. highlight his role as an influential inventor. His innovative methods for developing inhibitors and antibiotics demonstrate the importance of research and collaboration in advancing healthcare solutions.